Business Combinations (Details) - Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition (Parentheticals) - $ / shares	12 Months Ended
Dec. 31, 2023	Dec. 31, 2022
Schedule of Pro Forma Results Effects of ICU Eyewear Acquisition [Line Items]
Diluted	$ (92.80)	$ (878.14)

Pro forma diluted earnings per share, which is commonly presented in initial public offerings.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.B.3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480148/855-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 7
-Subparagraph (SAB Topic 1.B.2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480922/205-10-S99-7

Name:	us-gaap_DilutedEarningsPerShareProForma
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration